F33.2
Conditions
Interventions
Group 1: Patients with treatment-resistant depression who participate in the FORESEE III study and are treated with deep brain stimulation of the medial forebrain bundle are going to be parallely incl
participants in this arm are going to be measured twice (second time point is after four months without any intervention). Participants are informed and have to consent in this study. Then, everything
Sponsors
Department für Psychische ErkrankungenKlinik für Psychiatrie und PsychotherapieUniklinik FreiburgAbteilung für Interventionelle Biologische Psychiatrie
Eligibility
Sex/Gender
All
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria for patients with treatment-resistant depression are described in the main study investigating the efficacy of deep brain stimulation in treatment-resistant depression (registered at clinicaltrials.gov). For healthy controls, no inclusion criteria are defined. Healthy controls are matched.
Exclusion criteria
Exclusion criteria: Exclusion criteria for patients with treatment-resistant depression are described in the main study investigating the efficacy of deep brain stimulation in treatment-resistant depression (registered at clinicaltrials.gov). For healthy controls, no exclusion criteria are defined. Healthy controls are matched.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Emotion recognition (EmoDetect) and Theory of Mind (ToM) ability (EmpaToM) at baseline, comparision of patients with treatment-resistant depression and healthy controls. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change of emotion recognition and Theory of Mind ability after four months of treatment with active stimulation. | — |
Countries
Germany
Contacts
Public ContactHannah Kilian
Department für Psychische ErkrankungenKlinik für Psychiatrie und PsychotherapieUniklinik FreiburgAbteilung für Interventionelle Biologische Psychiatrie
Outcome results
None listed